NCT05920265

Brief Summary

evaluation the efficacy of Quadratus Lumborum plain Block Versus Fascia Iliac Block for postoperative pain after hip surgery

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Feb 2021

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2021

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 15, 2022

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2022

Completed
10 months until next milestone

First Submitted

Initial submission to the registry

June 16, 2023

Completed
11 days until next milestone

First Posted

Study publicly available on registry

June 27, 2023

Completed
Last Updated

June 27, 2023

Status Verified

June 1, 2023

Enrollment Period

1.4 years

First QC Date

June 16, 2023

Last Update Submit

June 16, 2023

Conditions

Keywords

QLBFascia Iliac Blockhip surgery

Outcome Measures

Primary Outcomes (1)

  • analgesic consumption

    intraoperative and post operative

    24 hour

Secondary Outcomes (2)

  • Visual analogue pain score

    24 hour

  • first analgesic demand

    24 hour

Study Arms (3)

Quadratus Lumborum Block

EXPERIMENTAL
Procedure: Quadratus Lumborum plain Block

Fascia Iliac Block

EXPERIMENTAL
Procedure: fascia iliaca block

control

ACTIVE COMPARATOR
Diagnostic Test: control group

Interventions

ultrasound guided Quadratus Lumborum plain Block using 0.5 ml/kg bupivacaine 0.25% .

Quadratus Lumborum Block

ultrasound guided fascia iliaca block using 0.5 ml/kg bupivacaine 0.25%

Fascia Iliac Block
control groupDIAGNOSTIC_TEST

no intervention

control

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • years
  • fracture hip

You may not qualify if:

  • patients refuse
  • mental problem patient with any coagulation deficiency or bleeding problems patient with allergy to investigated medications,

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Minia University

Minya, Minya Governorate, 61511, Egypt

Location

MeSH Terms

Conditions

Pain, Postoperative

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and Symptoms

Study Officials

  • abeer M hassaneen, Ass. professor

    minia university hospital/ faculty of medicine

    STUDY DIRECTOR
  • ahmed H Mohamed, Professor

    minia university hospital/ faculty of medicine

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
lecturer of anesthesia and ICU

Study Record Dates

First Submitted

June 16, 2023

First Posted

June 27, 2023

Study Start

February 1, 2021

Primary Completion

June 15, 2022

Study Completion

September 1, 2022

Last Updated

June 27, 2023

Record last verified: 2023-06

Data Sharing

IPD Sharing
Will not share

Locations